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Rationale: Neutrophils are usually the first circulating leukocytes to
respond during bacterial pneumonia. Their expression of oxidants,
proteases, and other mediators present in granules is well docu-
mented, but their ability to produce mediators through transcrip-
tion and translation after migration to an inflammatory site has
been appreciated only more recently. Interferon (IFN)-g is a cyto-
kine with many functions important in host defense and immunity.
Objectives: To examine the expression and function of IFN-g in
bacterial pneumonias.
Methods: IFN-g mRNA and protein were measured in digests of
mouse lungs with 24-hour bacterial pneumonia. Bacterial clear-
ance was studied with IFN-g–deficient mice.
Measurements and Main Results: Streptococcus pneumoniae and
Staphylococcus aureus each induce expression of IFN-g mRNA and
protein by neutrophils by 24 hours. Only neutrophils that have
migrated into pneumonic tissue produce IFN-g. Deficiency of Hck/
Fgr/Lyn, Rac2, or gp91phox prevents IFN-g production. IFN-g en-
hances bacterial clearance and is required for formation of neu-
trophil extracellular traps. In contrast, Pseudomonas aeruginosa and
Escherichia coli induce production of IFN-g mRNA but not protein.
During pneumonia induced by E. coli but not S. pneumoniae,
neutrophils produce microRNAs that target the 39 untranslated
region of the IFN-g gene.
Conclusions: S. pneumoniae and S. aureus, but not P. aeruginosa and
E. coli, induce emigrated neutrophils to produce IFN-g within
24 hours. Hck/Fgr/Lyn, Rac2, and NADPH oxidase are required
for IFN-g production. IFN-g facilitates bacterial clearance at least in
part through regulating formation of neutrophil extracellular
traps. Differential expression by neutrophils of microRNAs that
target the 39 untranslated region of the IFN-g gene may contribute
to the pathogen-specific regulation of translation.
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Interferon-g (IFN-g) is a pleiotropic cytokine that exerts its
effects through binding to a single receptor, which is expressed
on most cell types (1, 2). It is expressed primarily by T
lymphocytes (1, 2), although other cell types including neutro-
phils can produce it (3–10). The effects of IFN-g include
a number of roles in specific immune processes, including
modulation of the class I and II antigen–presenting pathways
and the development of helper T-cell type 1 (Th1) responses. It
plays important roles in controlling the cell cycle, growth, and
apoptosis. It also contributes to both innate and specific
immunity through activation of microbicidal effector pathways,
priming of LPS responses, and leukocyte trafficking.
Bacterial pneumonia is a particularly common and devastat-
ing public health problem that is associated with high morbidity,
mortality, and cost (11). Many studies from our laboratory and
others have focused on the host defense mechanisms that are
important in the recognition of pathogens in the lungs and the
recruitment of leukocytes to the lung tissue, including the
production of chemokines and cytokines such as IL-8, tumor
necrosis factor-a, IL-1, and IL-6. The role of IFN-g, as well as
IFN-a and -b, has been documented during viral infections (2,
12). However, its role in acute bacterial infections is less clear,
although some of its known functions in facilitating clearance of
bacteria and enhancing innate responses predict that it may
benefit host defense. The studies presented in this article
determine which cell type produces IFN-g during acute bacte-
rial pneumonia, how its production is regulated, and whether it
contributes to clearance of bacteria from the lungs. Initial
studies tested the hypotheses that IFN-g is produced early in
the course of acute bacterial pneumonias and that neutrophils
are the major source of IFN-g production at this time. Sub-
sequent studies tested the hypotheses that (1) the leukocyte
nonreceptor tyrosine kinases Hck, Fgr, and Lyn, the small
GTPase Rac2, and the NADPH oxidase component gp91phox
are required for production of IFN-g and (2) this IFN-g is
important in bacterial clearance from the lungs. Our observa-
tions that IFN-g mRNA is translated to protein in response to
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Neutrophils are widely recognized to produce reactive
oxygen species and proteases. However, their ability to
regulate the inflammatory process by producing cytokines
and other mediators in a highly regulated manner has many
unexplored aspects.
What This Study Adds to the Field
In mice, neutrophils produce IFN-g during pneumonia
induced by the bacterial pathogens Streptococcus pneumo-
niae and Staphylococcus aureus, but not in response to
Pseudomonas aeruginosa or Escherichia coli. IFN-g pro-
duction uses signaling pathways in neutrophils that include
nonreceptor Src tyrosine kinases, Rac2, and NADPH
oxidase and appears to be important in regulating the clear-
ance of bacteria.
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only some bacterial species led to the final hypothesis that
bacterial species that induce translation of IFN-g mRNA do not
induce microRNA (miR) targeted to the 39 untranslated region
(UTR) of the IFN-g gene, whereas those that do not cause IFN-g
mRNA translation do induce these miRs.
Two gram-positive and two gram-negative organisms were
selected for study: Streptococcus pneumoniae because it is the
most common cause of community-acquired pneumonia (13),
Staphylococcus aureus because it causes both community-
acquired and nosocomial pneumonias, Pseudomonas aeruginosa
because it is a common cause of nosocomial pneumonia, and
Escherichia coli because it is also a cause of nosocomial
pneumonia and pneumonia due to gram-negative sepsis (14)
as well as because of the many in vivo studies that have
examined this organism or its lipopolysaccharide (LPS). Pul-
monary inflammation induced by lipoteichoic acid (LTA) and
LPS, important constituents of the cell wall of gram-positive
and gram-negative organisms, respectively, was also examined.
Some of the results of these studies have been previously
reported in the form of abstracts (15–18).
METHODS
Reagents
Reagents used for this study were from the following sources: Dispase
II was from Roche Applied Science (Indianapolis, IN); fetal calf serum
(FCS), phosphate-buffered saline (PBS), collagenase type 1, TRIzol,
the SuperScript III first-strand synthesis system, NuPAGE LDS sample
buffer, a colloidal blue staining kit, and Alexa Fluor 546–conjugated
goat anti-mouse IgG antibody were from Invitrogen (Carlsbad, CA);
DNase I from bovine pancreas, red blood cell lysing buffer, para-
formaldehyde, LPS from E. coli O55:B5, LTA from S. aureus, protease
inhibitor cocktail, TRI Reagent, and 49,6-diamidino-2-phenylindole
(DAPI) were from Sigma-Aldrich (St. Louis, MO); the RNeasy mini
kit was from Qiagen (Valencia, CA). Protein L–agarose beads were
from Santa Cruz Biotechnology (Santa Cruz, CA). Cell lysis buffer was
from Cell Signaling Technology (Danvers, MA). Reagents for flow
cytometry were from the following sources: fluorescein isothiocyanate
(FITC)–conjugated rat anti-mouse CD45 antibody (clone 30-F11),
FITC-conjugated Armenian hamster anti-mouse CD3e antibody (clone
145-2C11), phycoerythrin (PE)-conjugated rat anti-mouse IFN-g anti-
body (clone XMG1.2), PE–cyanine 5 (Cy5)–conjugated rat anti-mouse
F4/80 (clone BM8) and Gr-1 (clone RB6–8C5) antibodies, allophyco-
cyanin-conjugated rat anti-mouse CD45 antibody (clone 30-F11),
fluorochrome-conjugated isotype control antibodies, brefeldin A,
and permeabilization buffer were purchased from eBioscience (San
Diego, CA); FITC-conjugated rat anti-mouse Ly-6G antibody (clone
1A8) and rat anti-mouse FcgIII/II receptor antibody (clone 2.4G2)
were purchased from BD Pharmingen (San Diego, CA); FITC-
conjugated anti-mouse neutrophil antibody (clone 7/4) was purchased
from Serotec (Raleigh, NC). Mouse monoclonal anti–pan-histone anti-
body was purchased from Millipore (Billerica, MA). Mouse monoclonal
anti-mouse myeloperoxidase (MPO) antibody (clone 8F4) was pur-
chased from Hycult Biotechnology (Uden, The Netherlands).
Bacteria
Streptococcus pneumoniae (S. pneumoniae; serotype 19, ATCC 49619),
Staphylococcus aureus (S. aureus; serotype 3, ATCC 12600), Escherichia
coli (E. coli; serotype O55:K59(B5):H-, ATCC 12014), and Pseudomonas
aeruginosa (P. aeruginosa; PAO-1, ATCC BAA-47) were purchased
from the American Type Culture Collection (Manassas, VA).
Mice
Adult C57BL/6 (wild-type) mice and IFN-g–deficient mice were
purchased from Jackson Laboratory (Bar Harbor, ME). Rac2 null
and gp91phox null mice were provided by M. C. Dinauer (Indiana
University, Indianapolis, IN). Hck/Fgr/Lyn triply and singly deficient
mice were provided by C. A. Lowell (University of California, San
Francisco, CA). All deficient mice were backcrossed to the wild-type
background. Mice were between 6 and 8 weeks of age in all
experiments. All studies were subject to review by the Institutional
Animal Care and Use Committee at the University of North Carolina
at Chapel Hill (Chapel Hill, NC) and conformed to the Guide for the
Care and Use of Laboratory Animals by the Institute of Laboratory
Animal Resources, Commission on Life Sciences, National Research
Council.
Induction of Bacterial Pneumonia and LPS- or LTA-induced
Lung Inflammation
Bacterial pneumonia and LPS- or LTA-induced lung injury were
induced by intratracheal instillation of 50 ml of bacterial suspension,
or of LPS (100 mg/mouse) or LTA (100 mg/mouse) solution, into
anesthetized mice. After exposure of the trachea through a ventral
incision in the neck, a 24-gauge catheter was threaded into the trachea
through a tracheostomy and positioned near the bifurcation. The mice
were positioned on their left side so that the bacteria instilled entered
the left lung. Previous experience in using this method showed that
greater than 90% of the stimulus entered the left lung. Concentrations
of bacterial suspensions were determined by optical density at 600 nm.
Optical density for each bacterial solution was as follows: S. pneumo-
niae, 1.0; S. aureus, 1.0; E. coli, 0.3; P. aeruginosa, 0.1. These con-
centrations yield doses that induce similar numbers of neutrophils to
migrate into murine lungs. Colony-forming units in bacterial solutions
were subsequently determined by serial dilution and colony counting
on agar plates. The ranges of colony-forming units were as follows,
unless otherwise indicated: S. pneumoniae, 2.8–20 3 106 cfu/mouse;
S. aureus, 8.5–13 3 107 cfu/mouse; E. coli, 3.8–18 3 106 cfu/mouse;
P. aeruginosa, 4.5–48.3 3 106 cfu/mouse.
Preparation of Single Lung Cells from Lungs
Six or 24 hours after instillation, mice received an overdose of inhaled
isoflurane. Their lungs were perfused with PBS via the right ventricles.
PBS-perfused lungs were isolated with other mediastinal organs.
Dispase II solution was instilled into lungs through the trachea, which
was ligated with a silk suture. After incubation for 50 minutes at 378C,
lungs were separated from other mediastinal organs. Left lung samples
were minced well and digested in PBS with 0.1% collagenase, 0.01%
DNase I, and 5 mM CaCl2 at 378C for 20 minutes. Cells were sus-
pended in red blood cell lysing buffer to remove red blood cells
and washed with PBS. Cells were centrifuged again and suspended in
PBS.
Bronchoalveolar Lavage
Bronchoalveolar lavage (BAL) was performed by instilling 1.0 ml of
ice-cold PBS into the lungs and then gently aspirating the fluid. BAL
was repeated five times. These five fluid samples were pooled and
centrifuged. BAL fluid cells were suspended in PBS.
Intracellular Staining for IFN-g
Isolated lung cells were incubated in medium (10% FCS–RPMI
1640) with brefeldin A (3.0 mg/ml) for 1 hour at 378C. Cells were
centrifuged and resuspended with 2% FCS–PBS. To prevent non-
specific binding of antibody to Fc receptors, cells were incubated
with rat anti-mouse CD16/CD32 antibody (mouse Fc Block; BD
Biosciences, San Jose, CA). Staining for cell surface antigens was
performed with fluorochrome-conjugated antibodies. Cells were washed
and fixed with 2% paraformaldehyde. Cells were washed again and
suspended with permeabilization buffer. Cells were then incubated
with PE-conjugated anti–IFN-g antibody or isotype control antibody.
Cells were washed and resuspended for flow cytometric analysis, using
a FACScan or LSR (BD Biosciences). In studies assessing IFN-g
production in neutrophils, the neutrophils were identified with the
FITC-conjugated rat anti-mouse Ly-6G antibody (clone 1A8). This
antibody is specific for neutrophils and recognizes only Ly6G (19). The
anti–Gr-1 antibody (clone RB6-8C5) was used only in experiments
where two neutrophil markers were required (intravascular neutrophils
and all neutrophils, please see details below). This anti–Gr-1 antibody
recognizes both Ly6G and Ly6C, which is expressed at low levels on
dendritic cells and some populations of monocytes, as well as on
neutrophils (19).
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Identification of Proteins Recognized by Anti-Mouse
IFN-g Antibody
Neutrophils were isolated from lung cell suspensions of mice with 24-
hour S. pneumoniae pneumonias (purity, .99%), using an anti–Ly-6G
MicroBead kit (Miltenyi Biotec, Bergisch Gladbach, Germany). The
neutrophils were fixed with 2% paraformaldehyde, washed, and
suspended in permeabilization buffer. Cells were then incubated with
anti–IFN-g antibody or isotype control antibody. Cells were washed,
and lysed with radioimmunoprecipitation assay (RIPA) buffer (150 mM
NaCl, 1% IGEPAL CA-630 [1% Nonidet P-40] containing 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris-HCl
[pH 7.5]), and a protease inhibitor cocktail. IFN-g–anti–IFN-g antibody
complexes were isolated with protein L–agarose beads that were
incubated with the lysate at 48C overnight. Samples were washed with
RIPA buffer five times and incubated with NuPAGE LDS sample
buffer to elute. Eluted samples were electrophoresed on a NuPAGE 4–
12% gradient bis-Tris sodium dodecyl sulfate–polyacrylamide gel.
After electrophoresis, the gel was stained with the colloidal blue
staining kit and cut into 11 pieces according to the distribution of
stained bands. The gel pieces were digested with trypsin (Promega,
Madison, WI) for 18 hours at 378C. Digests were injected into a liquid
chromatography–mass spectrometry system (UltiMate 3000 HPLC
Nano; Dionex, Sunnyvale, CA with C18 reverse phase columns and
a Fourier transform quadrupole ion trap mass spectrometer [LTQ FT
Ultra Hybrid Mass Spectrometer]; Thermo Scientific, Waltham, MA).
Data files were then processed with the Mascot search engine (Matrix
Science, Boston, MA), using the database NCBInr 20070216 (4,626,804
sequences; 1,596,079,197 residues).
ELISA for Detection of Mouse IFN-g
Lungs were harvested from mice 24 hours after instillation of S.
pneumoniae, E. coli, or PBS, and homogenized with cell lysis buffer
supplemented with a protease inhibitor cocktail. Supernatants were
used for ELISA, following the manufacturer’s instructions (mouse
IFN-g ‘Femto-HS’ high-sensitivity ELISA kit; eBioscience).
Identification of Intravascular and Extravascular Neutrophils
in Lungs
Identification of intravascular and extravascular neutrophils in lungs was
performed as previously described with modification (20). PE–Cy5–
conjugated anti-mouse Gr-1 antibody (10 mg) was injected intravenously
and allowed to circulate for 5 minutes. After 5 minutes, mice were killed.
The lungs were digested as described previously in the presence of excess
unlabeled anti-mouse Gr-1 antibody to prevent possible binding of excess
PE–Cy5–conjugated anti–Gr-1 antibody to extravascular neutrophils.
Lung cell suspensions were then stained with FITC-conjugated anti-mouse
neutrophil antibody (7/4). Intravascular (7/41Gr-11) and extravascular
(7/41Gr-12) neutrophil populations were assessed by flow cytometry.
Bacterial Numbers in Lungs
The number of viable bacteria was quantified by colony-forming
assays. Lungs were homogenized in sterile PBS, serially diluted, and
plated on Trypticase soy agar with 5% sheep blood (TSA II; BD
Diagnostic Systems, Sparks, MD). Bacterial colonies were counted after
being incubating overnight at 378C in 5% CO2. Clearance was calculated
as the number of colony-forming units remaining in the lungs at 24 hours
divided by the number of colony-forming units instilled.
Immunofluorescence Assays for Neutrophil
Extracellular Traps
Mice were given an intrabronchial instillation of S. pneumoniae (1.8–
3.1 3 106 cfu/mouse). After 24 hours, bronchoalveolar lavage fluid
(BALF) was collected. Cytospin slides of BALF were prepared. Cells
were fixed with 4% paraformaldehyde, blocked (4% normal goat
serum, 1% bovine serum albumin), and incubated with either the
anti-histone antibody or the anti-MPO antibody, which were detected
with a secondary antibody conjugated to Alexa Fluor 546. Control
slides were stained with isotype-matched controls. For DNA detection,
DAPI staining was performed. Neutrophil extracellular traps (NETs)
were counted and expressed per 500 neutrophils.
Pulmonary Edema
Plasma extravasation was quantified with radiotracers as described
previously (21). Briefly, anesthetized mice received intravenous injec-
tions of 125I-labeled human albumin (Mallinckrodt Medical, Hazelwood,
MO) 6 hours and 15 minutes before euthanasia and of 51Cr-labeled
murine erythrocytes 2 minutes before euthanasia, as markers of plasma
and blood content, respectively. Mice were killed by isoflurane overdose
24 hours after the intratracheal instillation of S. pneumoniae. The total
volume of plasma equivalents in the lungs was derived from the 125I-
labeled albumin activities in the lungs and plasma. The volume of
intravascular plasma in the lungs was calculated from the hematocrit
(derived from the 125I-labeled albumin activities in the blood and
plasma) and the pulmonary blood volume (derived from the 51Cr-
labeled red blood cell activity in the lungs and blood). The volume of
extravascular plasma equivalents in the lungs was calculated as the
total volume of plasma equivalents minus the volume of intravascular
plasma. The edema index was calculated as the volume of extravascular
plasma equivalents divided by the mouse body weight.
Isolation of Lung Neutrophils
Lung neutrophils were separated from lung cell suspensions, using the
anti–Ly-6G MicroBead kit (Miltenyi Biotec) according to the manu-
facturer’s protocol. Purity of isolated neutrophils was evaluated by
microscopic and flow cytometric analyses, and was more than 98%.
RNA Extraction, cDNA Synthesis, and Quantitative
Polymerase Chain Reaction
Total RNA was extracted from neutrophils, using the RNeasy mini kit.
cDNA was synthesized from total RNA, using the SuperScript III first-
strand synthesis system. IFN-g mRNA was quantified by quantitative
real-time polymerase chain reaction (PCR), using a specific primer set
(Mm99999071_m1) purchased from Applied Biosystems (Foster City,
CA). A primer set specific for 28S rRNA was also used for normalization
(sense primer, 59-TGTGGATGGCGAGAAATACCA-39; antisense
primer, 59-GCATCAGCCTCCAGTATAGTTGT-39).
Quantitative Reverse Transcription PCR for MicroRNAs
Quantitative reverse transcription PCR was performed as described
previously (22). Briefly, total RNA was isolated with TRI Reagent
(Sigma-Aldrich). The integrity of the total RNA was evaluated with
a 2100 Bioanalyzer and an RNA 6000 series II Nano kit (Agilent, Santa
Clara, CA). The TaqMan microRNA assay system (Applied Biosys-
tems) was used to quantitatively detect the expression of microRNAs,
in accordance with the manufacturer’s instructions. The primers used
in the TaqMan microRNA assay system were specific and recognized
the mature form of each microRNA. Real-time quantitative PCR was
conducted with the ABI 7500 real-time PCR system (Applied Bio-
systems). All reactions were done in technical triplicates. The relative
expression level of microRNAs was calculated by the 22DDCt method
(23) after normalization to the endogenous small RNA control, small
nucleolar RNA (snoRNA) 202.
Statistical Analyses
Data are expressed as means 6 SEM. Statistical analyses were performed
with Statistica software (StatSoft Inc., Tulsa, OK). Sets containing two
groups of data were analyzed by Student t test. Sets containing more than
two groups of data were analyzed by one-way analysis of variance with
a post hoc test (Scheffé test or Tukey HSD [honestly significantly
different] test). P values less than 0.05 were considered significant.
RESULTS
S. pneumoniae and S. aureus Induce Production of IFN-g
in Neutrophils, whereas E. coli, P. aeruginosa, LPS, and
LTA Do Not
Mice were given pneumonia by instilling into the left lung one
bacterial species, LPS, LTA, or PBS. After 24 hours, single-cell
lung digests were stained to identify neutrophils using the
neutrophil-specific anti-Ly6G antibody (clone 1A8) and IFN-g
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using an anti-mouse IFN-g antibody (clone XMG1.2). S.
pneumoniae and S. aureus induced a significant increase in the
percentage of neutrophils that contained intracellular IFN-g,
whereas E. coli, P. aeruginosa, LPS from E. coli, and LTA from
S. aureus did not (Figures 1A and 1B). Each stimulus induced
a significant accumulation of neutrophils, and the number of
accumulated neutrophils was similar among inflammatory stim-
uli (Figure 1C). Furthermore, IFN-g was present in lung homo-
genates from pneumonia induced by S. pneumoniae (3.4 6
0.18 pg/mg protein) but not E. coli (1.1 6 0.32 pg/mg protein)
compared with noninfected controls (1.9 6 0.05 pg/mg protein),
using an ELISA.
To further ensure the identity of the antigen recognized by
the anti–IFN-g antibody and to document the production of
Figure 1. Streptococcus pneumoniae and Staphylococcus aureus induced production of IFN-g in lung neutrophils by 24 hours, whereas Escherichia
coli, Pseudomonas aeruginosa, LPS, and lipoteichoic acid (LTA) did not. (A) Representative flow cytometric analyses to detect intracellular IFN-g in
neutrophils from single lung cells prepared from lung digests of mice given phosphate-buffered saline (PBS) (controls), gram-positive bacteria (S.
pneumonia or S. aureus), gram-negative bacteria (E. coli or P. aeruginosa), LPS, or LTA. Twenty-four hours after intraairway instillation of a stimulus,
lungs were perfused with PBS via the right ventricle. Dispase II solution was infused into the lungs through the trachea. After 50 minutes at 378C, the
left lungs were minced well and digested in PBS with 0.1% collagenase, 0.01% DNase I, and 5 mM CaCl2 at 378C for 20 minutes. Red blood cells
were lysed, and isolated lung cells were incubated in medium (10% fetal calf serum–RPMI 1640) with brefeldin A (3.0 mg/ml) for 1 hour at 378C,
followed by Fc Block. Neutrophils were identified with fluorescein isothiocyanate–conjugated rat anti-mouse Ly-6G antibody (clone 1A8), an
antibody that recognizes only neutrophils (19). Cells were fixed with 2% paraformaldehyde, suspended in permeabilization buffer, and incubated
with phycoerythrin-conjugated anti–IFN-g antibody or isotype control antibody. The percentage of cells in each quadrant is shown. (B) Mean
percentage of neutrophils producing IFN-g. (C ) Mean number of neutrophils in pneumonic lungs. The number of mice in each group was as follows:
PBS, n 5 9; S. pneumoniae, n 5 21; S. aureus, n 5 6; E. coli, n 5 15; P. aeruginosa, n 5 6; LPS, n 5 9; LTA, n 5 6. Shown are means 6 SEM of three to
seven separate experiments. (*P , 0.0001 vs. the PBS group, using analysis of variance with the Scheffé post hoc test.)
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IFN-g, neutrophils were isolated from S. pneumoniae lung
digests (.99% pure) and labeled with this antibody as for
flow cytometry. The antibody–antigen complexes were eluted and
electrophoresed, and gel segments were subjected to liquid
chromatography–mass spectrometry. IFN-g was identified in the gel
segment containing the appropriate molecular mass range (IFN-g,
18,123 Da) by four peptides: RLFEVLKD, KFEVNNPQVQRQ,
RQAFNELIRV, and RVVHQLLPESSLRK (Mascot score, 78;
P , 0.05). These four peptides cover 25.8% of the IFN-g pro-
tein and are shown highlighted in italic and bold in the IFN-g





The underlined residues were included in two peptides. The
only murine peptide/protein that was present in the fragment of
polyacrylamide gel that included the IFN-g molecular mass
range was IFN-g. Furthermore, no peptides mapping to IFN-g
were found in neutrophils of IFN-g–deficient mice, and neutro-
phils from mice deficient in the NADPH oxidase component
gp91phox, which is required for production of IFN-g (see below),
also did not produce IFN-g.
To better understand which leukocytes produced IFN-g
during S. pneumoniae pneumonia and the kinetics of IFN-g
expression, single cells from digests of lungs infected with S.
pneumoniae were stained with lineage-specific markers and anti–
IFN-g antibody (Table 1). The pan-leukocyte marker CD45
showed that leukocytes were making IFN-g 24 hours, but not
6 hours, after instillation of S. pneumoniae. At 24 hours, CD31
T cells, common producers of IFN-g, did not produce IFN-g.
In fact, no CD451Ly-6G2 cells expressed IFN-g. Immunostain-
ing of BAL fluid from lungs with S. pneumoniae pneumonia
demonstrated that only Ly-6G1 neutrophils, and not F4/801
macrophages, produced IFN-g (Table 1). Furthermore, circu-
lating neutrophils in blood from mice instilled with S. pneumo-
niae did not express IFN-g at 6 or 24 hours (Table 1), indicating
that only neutrophils recruited to the lungs expressed IFN-g
during S. pneumoniae pneumonia. Indeed, studies of 24-hour
S. pneumoniae pneumonias, in which intravascular neutrophils
were labeled in vivo with intravascular PE–Cy5–conjugated
anti-mouse Gr-1 antibody and all pulmonary neutrophils in the
lung digest were labeled with FITC-conjugated anti-mouse 7/4,
demonstrated that only the extravascular neutrophils (i.e., cells
labeled with anti-7/4 but not anti–Gr-1 antibody) produced
IFN-g (33.3 6 1.3% of extravascular neutrophils vs. 1.9 6 0.4%
of intravascular neutrophils). These observations suggest that
neutrophils are the major source of IFN-g production at 24
hours during S. pneumoniae pneumonia and that only the
extravascular neutrophils express IFN-g. However, the possibi-
lilty of an Ly6G2 cell type producing IFN-g cannot be completely
excluded.
Rac2, Hck/Fgr/Lyn, and gp91phox Are Required
for Neutrophils to Produce IFN-g
Other investigators have suggested that the small GTPase Rac2
may modulate IFN-g production by lymphocytes, and that the
three nonreceptor Src tyrosine kinases Hck, Fgr, and Lyn (Hck/
Fgr/Lyn) modulate Rac2 activation in neutrophils (24, 25). A
major function of Rac2 is to regulate the assembly of the
NADPH oxidase complex (26). The gp91phox component of
NADPH oxidase is required for the oxidase to produce
superoxide (26). To determine whether Hck/Fgr/Lyn, Rac2,
and NADPH oxidase are required for IFN-g production in
neutrophils during S. pneumoniae pneumonia, wild-type mice
and mice deficient in the either Hck, Fgr, or Lyn or all three
nonreceptor Src tyrosine kinases, the small GTPase Rac2, or the
NADPH oxidase component gp91phox were given S. pneumoniae.
At 24 hours, the number of neutrophils present in the pneu-
monic lungs was similar in all mutant genotypes compared with
wild-type (Table 2). However, the percentage of lung neutro-
phils that produced intracellular IFN-g in response to S.
pneumoniae was less in mice missing any one of these molecules
compared with wild-type mice (Table 2). Mice singly deficient in
either Hck, Fgr, or Lyn had no defect in IFN-g production.
These studies indicate that Hck/Fgr/Lyn, Rac2, and gp91phox are
each required for the production of IFN-g by neutrophils. The
molecules in this sequence (Hck/Fgr/Lyn:Rac2:NADPH oxi-
dase) form a well-described intracellular signaling pathway that
results in oxidant production, suggesting that oxidative stress is
required for IFN-g production.
TABLE 1. IFN-g IS PRODUCED BY NEUTROPHILS IN 24-HOUR S. pneumoniae PNEUMONIA
Percentage of Cells Producing IFN-g
Site of Cells Lineage-specific Marker Lineage Duration of Pneumonia (h) PBS (Control) S. pneumoniae
Lung digests CD45 All leukocytes 6 0.09 6 0.02, n 5 3 0.10 6 0.05, n 5 3
24 0.22 6 0.07, n 5 8 14.2 6 0.95,* n 5 14
CD3 T cells 24 0.23 6 0.06, n 5 3 0.47 6 0.10,† n 5 12
CD451, Ly-6G2 Nonneutrophilic leukocytes 24 ND 0.31 6 0.04,† n 5 3
CD451, Ly-6G1 Neutrophils 24 ND 21.98 6 3.43, n 5 6
BAL fluid F4/80 Macrophages 24 ND 0.08 6 0.11, n 5 3
Ly-6G Neutrophils 24 ND 16.4 6 1.5,‡ n 5 3
Circulating blood Ly-6G Neutrophils 6 0.02 6 0.04, n 5 3 0.04 6 0.02, n 5 3
24 0.20 6 0.20, n 5 3 0.32 6 0.16, n 5 3
Definition of abbreviations: BAL 5 bronchoalveolar lavage; ND 5 not determined; PBS 5 phosphate-buffered saline; S. pneumoniae 5 Streptococcus pneumoniae.
Flow cytometry was performed to detect intracellular IFN-g levels in all leukocytes (CD451 cells), T cells (CD31 cells), nonneutrophils (CD451Ly-6G2 cells), and
neutrophils (CD451Ly-6G1) in the lungs of S. pneumoniae–infected or PBS-treated mice 6 or 24 hours after instillation. Isotype-matched control antibody was used to
assess the level of background staining and to set gates. The percentages of cells in each quadrant and the means of the percentage in the double-positive quadrant were
calculated for the number of animals indicated. IFN-g expression was similarly measured in F4/80- and Ly-6G–positive cells from the BAL fluid and circulating blood (n 5
6 in each group). Neutrophils in the lung digests or the BAL fluid from pneumonic lungs at 24 hours expressed IFN-g. None of the other leukocyte subtypes were found
to produce IFN-g using this approach. Data represent means 6 SEM, and the number of mice (n) is provided for each study. The results are from three to six separate
experiments.
* P , 0.001 versus the PBS group.
† P , 0.01 versus the CD45 group.
‡ P , 0.05 versus the F4/80 group.
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IFN-g Modulates Bacterial Clearance and Host Defense
To elucidate the function of IFN-g during host defense against
S. pneumoniae, IFN-g2/2 and wild-type mice received varying
doses of S. pneumoniae (which induced IFN-g production) or
E. coli (which did not). Significantly more viable S. pneumoniae
were present in the lungs of IFN-g2/2 mice compared with
wild-type mice 24 hours after instillation of the lowest dose
(2.8–5.0 3 106 cfu/mouse) of S. pneumoniae (Table 3). At a mid-
level dose of 7.4–11 3 106 cfu or a high dose of 13–66 3 106 cfu,
there was no significant difference between wild-type and IFN-
g2/2 mice. IFN-g2/2 mice given E. coli, which did not induce
intracellular IFN-g protein expression by neutrophils, had no
defect in clearance of either dose (Table 3). These data suggest
that IFN-g is required for host defense against S. pneumoniae,
particularly at low doses, but not E. coli.
There are several mechanisms through which IFN-g may be
facilitating bacterial clearance. Neutrophil extracellular traps
(NETs) were described by Brinkmann and colleagues in 2004
(27). This structure is extruded by neutrophils, most likely as
a form of cell death, and contains nuclear material and granular
contents such as myeloperoxidase and elastase but not actin.
NETs trap microorganisms and have bactericidal capabilities, at
least in part due to the histones (27). Their production requires
NADPH oxidase (28), and IFN-g has been suggested to
modulate NET formation (29). Our studies tested the hypoth-
esis that IFN-g produced early in the course of S. pneumoniae
pneumonia by neutrophils facilitated NET formation and hence
the clearance of bacteria. NETs were found by immunostaining
and colocalization of either DNA plus MPO or DNA plus
histones (Figure 2A). Significantly fewer NETs were present in
the BAL fluid of IFN-g2/2 mice than in that of wild-type mice.
This defect in NET formation observed in IFN-g mice was
similar in degree to the defect in mice missing the gp91phox
component of NADPH oxidase (which do not produce IFN-g in
TABLE 2. INTRACELLULAR SIGNALING MOLECULES REQUIRED FOR IFN-g PRODUCTION BY NEUTROPHILS DURING
S. pneumoniae PNEUMONIA
Percentage of Neutrophils Producing IFN-g Number of Neutrophils in Pneumonic Lung (3 106)
Mice Deficient in: Wild-type Mice Deficient Mice Wild-type Mice Deficient Mice
Hck/Fgr/Lyn 29 6 5.8 2.8 6 0.7* 25 6 5.3 23 6 5.9
Hck 9.3 6 0.6 15 6 6.6
Fgr 14 6 0.83 12 6 1.5 20 6 1.4 19 6 1.0
Lyn 14 6 1.6 26 6 3.6
Rac2 26 6 6.7 6.6 6 1.2* 18 6 3.9 23 6 2.6
gp91phox 22 6 1.8 1.2 6 0.2* 20 6 1.7 23 6 3.5
The nonreceptor Src tyrosine kinases Hck, Fgr, and Lyn, the small GTPase Rac2, and the gp91phox component of the NADPH oxidase complex are required for IFN-g
production by neutrophils during Streptococcus pneumoniae pneumonia. Flow cytometry was performed to detect intracellular IFN-g levels in neutrophils (CD451Ly-
6G1) in the lungs of S. pneumoniae–infected or PBS-treated mice 24 hours after instillation. Isotype-matched control antibody was used to assess the level of background
staining and to set gates. The mutant genotypes were compared with coincidently studied matching wild-type mice. The percentages of cells in each quadrant and the
means of the percentage in the double-positive quadrant were calculated for the number of animals indicated below. Data are expressed as means 6 SEM to two
significant figures, n > 5. For each genotype, two or three separate experiments were performed. Comparisons were made using two-tailed t tests, except for the single
Src kinase family mutants, for which analyses of variance were used.
* P , 0.05 versus wild-type mice.
TABLE 3. CLEARANCE OF BACTERIA, ACCUMULATION OF NEUTROPHILS IN PNEUMONIC LUNGS, CIRCULATING NEUTROPHIL
COUNTS, AND PULMONARY EDEMA IN THE LUNGS OF IFN-g–DEFICIENT AND WT MICE DURING BACTERIAL PNEUMONIA
Component of Host Defense Organism Dose Wild-type Mice IFN-g–deficient Mice




1.2 6 0.3, n 5 7
3.3 6 1.1, n 5 8
8.0 6 0.7,* n 5 7
2.2 6 0.6, n 5 6
High 20.2 6 1.8, n 5 5 20.8 6 5.1, n 5 7
E. coli Low 0.16 6 0.05, n 5 7 0.24 6 0.08, n 5 6
High 1.4 6 0.3, n 5 6 0.90 6 0.3, n 5 6
Neutrophil accumulation in the lungs
(3 106 per lung)
S. pneumoniae Low
High
17.6 6 1.7, n 5 6
30.6 6 3.4, n 5 4
30.7 6 4.5,* n 5 6
35.9 6 7.8, n 5 4
E. coli Low 8.4 6 1.1, n 5 6 8.2 6 1.1, n 5 6
High 17.4 6 1.3, n 5 6 28.6 6 3.2,* n 5 8
Circulating neutrophil counts







Edema index (n 5 5) S. pneumoniae Low 0.61 6 0.08 0.60 6 0.08
High 1.42 6 0.45 0.85 6 0.1
Definition of abbreviations: cfu 5 colony-forming units; E. coli 5 Escherichia coli; S. pneumoniae 5 Streptococcus pneumoniae.
Bacterial clearance at 24 hours was decreased in IFN-g–deficient mice given low-dose S. pneumoniae (2.8–5.0 3 106 cfu/mouse). No defect in clearance was observed
after mid-dose S. pneumoniae (7.4–11 3 106 cfu/mouse) or high dose S. pneumoniae (13–66 3 106 cfu/mouse) or either dose of E. coli (low dose, 1.9–2.8 3 106 cfu/
mouse; high dose, 9.5–24 3 106 cfu/mouse). Neutrophil recruitment was enhanced in IFN-g–deficient mice during S. pneumoniae pneumonia induced by low-dose
(1.0–6.0 3 106 cfu/mouse) but not high-dose (34–48 3 106 cfu/mouse) S. pneumoniae at 24 hours, paralleling the defect in clearance of S. pneumoniae. No defect in
neutrophil accumulation was observed with low-dose E. coli (1.2–2.6 3 106 cfu/mouse), also similar to the lack of defect in clearance of this organism, but enhanced
accumulation was found in IFN-g–deficient mice with high-dose (19–29 3 106 cfu/mouse) E. coli pneumonia. Circulating neutrophil counts and pulmonary edema
during pneumonia induced with either low-dose (1.8–2.0 3 106 cfu/mouse) or high-dose (17–20 3 106 cfu/mouse) S. pneumoniae were similar in IFN-g–deficient and
wild-type mice. Data represent means 6 SEM, and the number of mice is indicated. For each study, two separate experiments were performed. Statistical significance
was determined by analyses of variance and the Tukey HSD (honestly significantly different) post hoc test.
* P , 0.05 compared with wild-type mice.
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response to S. pneumoniae), whether evaluated by quantifying
the number of NETs by colocalization of DNA plus MPO
(Figure 2B) or DNA plus histones (Figure 2C). Thus, IFN-g is
modulating bacterial clearance at least in part through its effects
on NET formation.
The number of neutrophils recruited to the lungs 24 hours
after instillation of lower dose S. pneumoniae in IFN-g2/2 mice
was higher than in wild-type mice (Table 3), demonstrating that
the impairment of S. pneumoniae clearance in IFN-g2/2 mice is
not due to the attenuated infiltration of neutrophils. The
number of circulating neutrophils in the blood of IFN-g2/2
mice was also greater than in wild-type mice (Table 3). Lung
injury measured as the accumulation of edema (extravascular
125I-labeled albumin accumulation) in the last 6 hours of S.
pneumoniae pneumonia was similar between genotypes (Table
3), suggesting that the increased number of neutrophils did not
enhance lung injury. The number of neutrophils recruited to
high-dose E. coli pneumonias was also increased despite no
defect in clearance. Because these studies raised the possibility
that IFN-g expression occurs in response to higher (19–29 3 106
cfu/mouse) doses of E. coli, additional studies were performed
using 25 3 106 cfu/mouse. However, only 5.4 6 1.0% of
neutrophils expressed IFN-g in these pneumonias, which is
similar to the value of 5.7 6 0.8% of IFN-g1 neutrophils in the
lungs of mice given lower doses in Figure 1B (3.8–18 3 106 cfu/
mouse), and to mice given PBS (Figure 1B). The mechanism for
this increase in neutrophil accumulation is thus not yet clear.
IFN-g mRNA and Protein Are Differentially Expressed
High-quality RNA was extracted from neutrophils isolated
from lung digests (.98% purity), and IFN-g mRNA was
measured by real-time quantitative PCR. Although IFN-g
protein was expressed only by neutrophils from S. pneumoniae
and S. aureus pneumonias, IFN-g mRNA was significantly
induced 7- to 40-fold in lung neutrophils by all inflammatory
stimuli at 24 hours, including S. pneumoniae, S. aureus, E. coli,
P. aeruginosa, LPS, and LTA (Table 4). These studies suggest
that each stimulus induces transcription of IFN-g by neutro-
phils, but that translation occurs only in S. pneumoniae and
S. aureus pneumonia. Furthermore, neutrophils from gp91phox-
deficient mice given S. pneumoniae pneumonia did not express
IFN-g mRNA (9.6 6 0.68-fold vs. 0.72 6 0.088-fold change in
IFN-g mRNA compared with PBS-treated control in wild-type
and gp91phox-deficient mice, respectively), demonstrating that
NADPH oxidase is important in the transcription of IFN-g.
These studies led to the hypothesis that differential expres-
sion of microRNAs induced by E. coli but not S. pneumoniae
results in inhibition of IFN-g translation. MicroRNAs are 18- to
25-nucleotide noncoding RNAs that bind to the noncoding 39
UTR and either suppress translation or result in RNA degra-
Figure 2. IFN-g is required for host defense against
Streptococcus pneumoniae. (A) Representative immunomi-
crographs of neutrophils and neutrophil extracellular traps
(NETs) after immunofluorescence and 49,6-diamidino-2-
phenylindole staining to detect histones or myeloperoxi-
dase (MPO) and DNA in neutrophils from bronchoalveolar
lavage fluid 24 hours after instillation of low-dose S.
pneumoniae (1.4–4.1 3 106 cfu/mouse). Top row: Naı̈ve
neutrophils showed DNA (red ) and MPO (green) located
in nuclei and cytoplasm, respectively. The usual lobular
structure of nuclei was present. MPO stained in a granular
cytoplasmic pattern. Second row: In pneumonic lungs,
neutrophils in the early phase of NET formation showed
colocalization (yellow) of nuclear DNA and MPO. Cells
were losing their nuclear lobules, and MPO was present in
the nucleus. Third and fourth rows: In the late phase of NET
formation, neutrophils released NETs. Immunomicroscopy
showed colocalization of nuclear DNA and MPO (yellow)
and of nuclear DNA and histone (pink) in released NETs.
Scale bars: 10 mm. (B and C ) Quantification of NETs
identified by colocalization of (B) DNA and MPO or (C )
DNA and histones in wild-type, IFN-g2/2, and gp91phox2/2
mice. IFN-g was required for the production of NETs, when
identified by either DNA plus MPO or DNA plus histone
staining. The defect in NET formation in IFN-g2/2 mice was
similar to that in mice missing gp91phox, a subunit of
NADPH oxidase known to be required for NET formation.
Shown are means 6 SEM, n 5 6 mice of each genotype
studied in two separate experiments. (*P , 0.05 vs. wild-
type mice, using analysis of variance with the Tukey HSD
[honestly significantly different] post hoc test.)
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dation (30, 31). Using the two databases, miRBase (32, 33) and
microRNA.org (34, 35), microRNAs were identified that (1)
recognized the noncoding region of the murine IFN-g gene and
(2) were expressed by neutrophils (36). Searches revealed 17
microRNAs that fit these two criteria (Table 5), and the
expression of these 17 microRNAs was quantified by real-time
PCR in neutrophils from lungs exposed to S. pneumoniae,
E. coli, and PBS. In addition to these 17 microRNAs, miR-9
and miR-122 also recognize the noncoding region of IFN-g, but
they are not produced by neutrophils. miR-9 was included
because it is highly expressed in other cell types, though not
in CD151 granulocytes (36). miR-122 was included because it
is down-regulated by IFN-b, which is expressed in S. pneumo-
niae but not E. coli pneumonia (our unpublished data). The
data show that RNA isolated from lung neutrophils was high
in quality, as assessed with the 2100 bioanalyzer (Agilent). As
expected, miR-9 and miR-122 were not expressed in neutrophils
from lungs exposed to PBS, S. pneumoniae, or E. coli. S.
pneumoniae induced production of two microRNAs (miR-29b
and miR-29c), compared with PBS, whereas E. coli induced
production of these two microRNAs and eight others (asterisk,
relative amount; Table 6). Most importantly, seven microRNAs
were expressed to a greater degree in E. coli than S. pneumo-
niae pneumonia, as measured by the fold change from levels
found in control PBS lungs (dagger, Table 6; miR-15b, miR-26a,
miR-26b, miR-29a, miR-30b, miR-93, and miR-106b). The
increase in expression induced by E. coli compared with S.
pneumoniae ranged from 56 to 228% (Table 6). None of the
measured microRNAs were expressed only in S. pneumoniae
but not E. coli. Thus, these observations show that during
pneumonia, differential expression of multiple microRNAs that
target the noncoding region of IFN-g occurs. We postulate that
this differential expression provides a mechanism to explain the
failure of neutrophils to translate IFN-g mRNA to protein in E.
coli pneumonia.
DISCUSSION
These studies demonstrate the surprising and unexpected
finding that neutrophils are producing IFN-g early in the
inflammatory response during pneumonia induced by some
bacteria, but not others. Although the possibility that another
cell type also contributes to IFN-g production by this 24-hour
time point cannot be completely excluded, the only CD45+
leukocyte producing IFN-g expresses the neutrophil-specific
surface marker, Ly6G (19). S. pneumoniae and S. aureus
induced the production of IFN-g, whereas P. aeruginosa and
E. coli did not. Neither LPS nor LTA, two lipid substances
within the wall of gram-negative and gram-positive organisms,
respectively, induced IFN-g production by neutrophils, suggest-
ing that other components of bacteria were regulating IFN-g
production either directly or through host defense molecules.
IFN-g was produced only by neutrophils that had emigrated into
the tissue at 24 hours and was not present at 6 hours post-
infection. Neither circulating neutrophils nor neutrophils within
the pulmonary microvasculature that had not yet migrated
expressed IFN-g. Whether the process of migration is critical
for IFN-g production or whether the time needed to migrate is
required for the production of this cytokine remains a question.
IFN-g production was documented by three different ap-
proaches. Flow cytometry was used to document intracellular
IFN-g and the cell type that was producing it. To confirm that
the anti–IFN-g antibody was specifically identifying intracellu-
lar IFN-g, the antigen recognized by the antibody was de-
termined by mass spectroscopy and confirmed to be murine
IFN-g. The presence of IFN-g in the tissue was documented by
sensitive ELISAs. Last, IFN-g mRNA was produced by neu-
trophils. These data clearly document that neutrophils were
producing IFN-g and that this cytokine was expressed early
in the inflammatory response to these two gram-positive
organisms.
Our studies are not the first to demonstrate that IFN-g is
produced by neutrophils. In 1998, Yeaman and colleagues
demonstrated that neutrophils in the stroma of the uterus stain
for IFN-g at all stages of the cycle, as do circulating neutrophils
from the blood treated ex vivo with IL-12 (3). Kirby and
colleagues demonstrated that splenic neutrophils and macro-
phages produced IFN-g in response to Salmonella infection (4,
37, 38). During early graft loss of pancreatic islet transplants,
NK T cells stimulate production of IFN-g by neutrophils (10).
Early in renal ischemia–reperfusion injury, NK T cells also
induced expression of IFN-g in neutrophils within the kidney
(9). Furthermore, Ellis and Beaman demonstrated that neutro-
phils within the lungs produced IFN-g in response to Nocardia
asteroides (7). Most recently, Nance and colleagues demon-
strated that neutrophils generate IFN-g mRNA and protein in
response to intrapulmonary Saccharopolyspora rectivirgula, an
infection that mimics hypersensitivity pneumonitis (39). Our
studies are the first to identify neutrophils as a source of IFN-g
in acute bacterial pneumonias, to demonstrate that neutrophils
transcribe mRNA, and to address both the function of IFN-g
and the mechanisms through which it is regulated.
These studies also examined the pathways required to pro-
duce this IFN-g. The nonreceptor Src tyrosine kinases Fgr/Hck/
Lyn, the small GTPase Rac2, and the NADPH oxidase com-
ponent gp91phox were also each required for the production of
IFN-g. Other studies have demonstrated that outside/in intra-
cellular signaling initiated by ligation of CD18 can result in the
activation of these Src kinases (40, 41). In turn, these Src kinases
activate Rac2 (25), which is required for activity of the assembled
NADPH oxidase complex, resulting in the production of oxi-
dants (26). Whether this CD18:Fgr/Hck/Lyn:Rac2:NADPH oxi-
dase pathway is the signaling pathway critical in the production
of IFN-g, or whether each of these molecules is critical in other
pathways resulting in IFN-g production, remains to be deter-
mined. However, our data clearly show that Rac2, Fgr/Hck/Lyn,
and NADPH oxidase are each required for IFN-g production by
neutrophils. Taken together, these data suggest that production
TABLE 4. IFN-g mRNA IN LUNG NEUTROPHILS AS DETECTED
BY QUANTITATIVE PCR
Organism or Bacterial Component Relative Amount of IFN-g mRNA*
PBS 1.0 6 0.0, n 5 18
S. pneumoniae 15.9 6 0.9,† n 5 24
S. aureus 37.7 6 2.8,‡ n 5 6
E. coli 39.0 6 5.7,‡ n 5 21
P. aeruginosa 26.2 6 7.1,‡ n 5 12
LPS 7.2 6 1.2,† n 5 15
LTA 19.2 6 0.7,† n 5 6
Definition of abbreviations: E. coli 5 Escherichia coli; LTA 5 lipoteichoic acid; P.
aeruginosa 5 Pseudomonas aeruginosa; PBS 5 phosphate-buffered saline; S.
aureus 5 Staphylococcus aureus; S. pneumoniae 5 Streptococcus pneumoniae.
IFN-g mRNA or 28S rRNA (internal control) in each sample of lung neutrophils
was detected by quantitative PCR. Data are expressed as the fold increase in
IFN-g mRNA expression compared with PBS-treated control. Data represent
means 6 SEM of IFN-g mRNA levels in lung neutrophils. Statistical significance
was determined by analysis of variance with the Scheffé post hoc test. The
number of mice (n) is provided. For each stimulus, three to eight separate
experiments were performed.
* PBS 5 1.
† p , 0.05 versus PBS group.
‡ p , 0.001 versus PBS group.
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of oxidants and the result oxidative stress may regulate pro-
duction of IFN-g mRNA.
Curiously, all four organisms, as well as LPS and LTA, result
in the production of IFN-g mRNA, but only S. pneumoniae and
S. aureus resulted in the expression of protein from the message.
These data suggest that the translation of IFN-g mRNA to
protein is the critical step in the mechanism underlying this
differential expression. Our studies examined the hypothesis
that differential expression of microRNAs targeted to the non-
coding region of IFN-g may be the mechanism through which
translation is differentially regulated, by quantifying the expres-
sion of 17 microRNAs identified through database searches as
having sequences that potentially recognize the noncoding re-
gion of the IFN-g mRNA and are produced by neutrophils. Our
results show that eight microRNAs are induced in E. coli but
not S. pneumoniae pneumonias (Tables 5 and 6), and the ex-
pression of these microRNAs correlates with the lack of trans-
lation of IFN-g mRNA. None of these 17 microRNAs was
differentially induced only in S. pneumoniae pneumonia, in
which both IFN-g mRNA and protein are produced. Although
these data do not prove that these microRNAs are the mecha-
nism for the differential expression of IFN-g protein from
mRNA induced by S. pneumoniae and S. aureus compared
with E. coli, P. aeruginosa, LPS, and LTA, they do provide
evidence that this may in fact be the mechanism. This inhibition
of translation may be due to the cumulative effect of the 56–
TABLE 5. microRNAs THAT TARGET THE 39 UNTRANSLATED REGION OF IFN-g mRNA AND ARE
EXPRESSED IN LUNG NEUTROPHILS*
miRNA
Binding Site of miRNA
on 39 UTR of IFN-g mRNA miRNA Gene Location
P Value Comparing
S. pneumoniae and E. coli
miR-15a 376 14: 62250864–62250947 [–] 0.046
miR-15b 375 3: 68813694–68813757 [1] 0.040
miR-26a 36 9: 118940914–118941003 [1] 0.021
miR-26b 37 1: 74440884–74440968 [1] 0.019
miR-29a 503 6: 31012660–31012747 [–] 0.008
miR-30b 393 15: 68168977–68169072 [–] 0.008
miR-106b 410 5: 138606965–138607046 [–] 0.031
miR-424 376 X: 50407432–50407526 [–] 0.043
miR-16 376 14: 62250717–62250809 [–]
3: 68813824–68813918 [1]
P > 0.05
miR-17 408 14: 115442893–115442976 [1] P > 0.05
miR-27a 247, 531 8: 86732571–86732657 [1] P > 0.05
miR-27b 247, 531 13: 63402020–63402092 [1] P > 0.05
miR-29b 506 6: 31013023–31013093 [–] P > 0.05
miR-29c 503 1: 196863741–196863828 [1] P > 0.05
miR-93 412 5: 138606751–138606838 [–] P > 0.05
miR-99b 271 17: 17967152–17967221 [1] P > 0.05
miR-186 226 3: 157207243–157207313 [1] P > 0.05
Definition of abbreviations: E. coli 5 Escherichia coli; miRNA 5 microRNA; S. pneumoniae 5 Streptococcus pneumoniae; UTR 5
untranslated region.
P values were calculated by comparing the DCt values by analysis of variance and Scheffé post hoc test. Data represent means 6
SEM of microRNA levels in lung neutrophils from nine mice studied in three separate experiments.
* See References 32–36.
TABLE 6. EXPRESSION OF microRNAs IN LUNG NEUTROPHILS DURING PNEUMONIA
miRNA
DCt Relative Amount of miRNA
Percentage Difference in
E. coli Compared with S. pneumoniaePBS S. pneumoniae E. coli PBS S. pneumoniae E. coli
miR-15a 4.59 6 0.04 4.48 6 0.11 4.19 6 0.06*† 1.00 6 0.03 1.10 6 0.09 1.32 6 0.06* 22
miR-15b 2.09 6 0.03 2.14 6 0.13 1.03 6 0.49† 1.00 6 0.02 1.00 6 0.08 3.28 6 1.05*† 228
miR-16 21.06 6 0.02 21.05 6 0.16 21.42 6 0.12 1.00 6 0.02 1.05 6 0.13 1.32 6 0.11 27
miR-17 3.26 6 0.02 3.56 6 0.40 3.11 6 0.31 1.00 6 0.01 1.14 6 0.34 1.30 6 0.21 16
miR-26a 1.65 6 0.03 1.90 6 0.20 1.12 6 0.24† 1.00 6 0.02 0.92 6 0.14 1.60 6 0.22*† 68
miR-26b 3.80 6 0.04 3.74 6 0.16 3.15 6 0.17*† 1.00 6 0.02 1.10 6 0.13 1.66 6 0.21*† 56
miR-27a 4.05 6 0.03 4.15 6 0.14 3.83 6 0.27 1.00 6 0.02 0.96 6 0.08 1.34 6 0.25 38
miR-27b 5.13 6 0.03 5.51 6 0.32 5.06 6 0.26 1.00 6 0.02 0.92 6 0.20 1.17 6 0.17 25
miR-29a 3.42 6 0.03 3.08 6 0.19 2.46 6 0.10*† 1.00 6 0.02 1.36 6 0.20 1.98 6 0.14*† 64
miR-29b 6.83 6 0.05 5.92 6 0.05* 5.99 6 0.23* 1.01 6 0.04 1.90 6 0.07* 1.99 6 0.34* 9
miR-29c 7.81 6 0.04 7.25 6 0.14* 6.97 6 0.08* 1.00 6 0.03 1.53 6 0.17* 1.82 6 0.10* 29
miR-30b 1.50 6 0.02 1.60 6 0.09 0.95 6 0.22*† 1.00 6 0.01 0.94 6 0.06 1.59 6 0.22*† 65
miR-93 1.57 6 0.02 2.08 6 0.26 1.27 6 0.35 1.00 6 0.02 0.80 6 0.15 1.50 6 0.28† 70
miR-99b 6.60 6 0.04 7.29 6 0.53 6.55 6 0.29 1.00 6 0.03 1.04 6 0.35 1.22 6 0.25 18
miR-106b 4.22 6 0.02 4.18 6 0.15 3.60 6 0.20*† 1.00 6 0.02 1.08 6 0.12 1.65 6 0.20*† 57
miR-186 8.82 6 0.07 9.41 6 0.23 8.75 6 0.23 1.01 6 0.05 0.74 6 0.12 1.15 6 0.15 41
miR-424 5.18 6 0.02 5.19 6 0.14 4.81 6 0.11† 1.00 6 0.01 1.03 6 0.11 1.32 6 0.10* 29
Definition of abbreviations: E. coli 5 Escherichia coli; miRNA 5 microRNA; PBS 5 phosphate-buffered saline; S. pneumoniae 5 Streptococcus pneumoniae.
Data represent means 6 SEM of microRNA levels in lung neutrophils from nine mice in each group (PBS, S. pneumoniae, E. coli). The DCt value was calculated by
normalizing for the expression of snoRNA 202 in each sample. Statistical significance was determined by analysis of variance and Scheffé post hoc test for DCt values and
the relative amounts of miRNA.
* P , 0.05 versus the PBS group.
† P , 0.05 versus the Streptococcus pneumoniae group.
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228% increases in these differentially expressed microRNAs.
Furthermore, five of the eight differentially expressed micro-
RNAs target sites within region 375–412 of the IFN-g gene
(Table 5), which may also enhance the effect of each. Moreover,
the ability of E. coli to induce the production of these micro-
RNAs targeted to IFN-g may represent a novel strategy by
which this pathogen can evade host defenses, which could also
be shared by other pathogens toward IFN-g or other host genes.
How the genes for these microRNAs are regulated is an
important question. The gene miR-106b is regulated by the
E2F1 transcription factor (42). The expression of miR-15a and
miR-26a is modulated by c-Myc (43, 44). However, to our
knowledge, these are the only studies examining the regulation
of these differentially regulated miR genes, and determining
whether a common regulator might be increased in E. coli but
not S. pneumoniae pneumonia is not yet possible until more
information about the transcription factors modulating these
genes is available.
Most importantly, our studies demonstrate that IFN-g pro-
duction modulates host defense against pneumonia. Bacterial
clearance of S. pneumoniae (2.8–5.0 3 106 cfu/mouse) from the
lungs is eightfold less in IFN-g–deficient compared with wild-
type mice. This poor clearance is accompanied by an increase in
neutrophils, which is most likely the result of increased numbers
of organisms. In contrast, during E. coli pneumonia, in which
IFN-g is not produced, there is no difference in bacterial
clearance between these two genotypes. Studies to understand
how IFN-g is altering bacterial clearance demonstrate that the
production of NETs was highly dependent on the production of
IFN-g. NETs are an important bactericidal mechanism in
neutrophils, as important or more important than phagocytosis
in sepsis and likely in later stages of the neutrophil life span (27,
28). Studies have demonstrated that neutrophils from neonates
have no defect in IL-8 production but do have a defect in NET
formation compared with neutrophils from adults, and this
defect correlated with a deficit in extracellular bacterial killing
(45). In addition, the production of NETs was much greater in
response to S. aureus than E. coli in vitro (46), which, when
considered in light of our observation that S. aureus but not E.
coli induces production of IFN-g, further suggests that IFN-g
is required for robust generation of NETs. Thus, our studies
suggest that IFN-g is regulating the formation of NETs, a highly
bactericidal effector mechanism by neutrophils, and that this
NET formation is responsible for the poor clearance of S.
pneumoniae in IFN-g–deficient animals. Other functions for
IFN-g also seem likely, for example, in regulating the balance
between Th1 and Th2 responses and the production of gran-
ulomas (7, 37–39, 47).
In summary, these studies demonstrate that neutrophils
produce IFN-g in response to S. pneumoniae and S. aureus
pneumonias in mice and that this IFN-g production is important
in host defense and the clearance of organisms from the lungs.
These studies add to a growing list of critically important
functions of neutrophils not only in releasing preformed gran-
ular contents and in generating reactive oxygen species but also
in synthesizing regulatory molecules that modulate the inflam-
matory and innate immune responses (48, 49). IFN-g pro-
duction is highly regulated, and these studies begin to identify
the signaling molecules that are important in the production of
IFN-g by these cells. The clinical relevance of the production
of IFN-g by neutrophils at this early time in the evolution of
bacterial pneumonia is demonstrated by the defect in host
defense that results when IFN-g cannot be produced. These
studies also suggest that host defense may be enhanced by the
administration of exogenous IFN-g in susceptible patient pop-
ulations. In fact, IFN-g is already used in patients with chronic
granulomatous disease, in which NADPH oxidase is genetically
dysfunctional. Thus, the induction of IFN-g and its function
have important therapeutic implications.
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